Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Bayer plc, 400 South Oak Way, Reading, RG2 6AD
Noristerat 200mg, solution for intramuscular injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. |
1ml Noristerat contains 200mg norethisterone enantate in oily solution.
Excipient with known effect: 333.8 mg benzyl benzoate in 1 ml ampoule.
For the full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Norethisterone |
Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle. |
| List of Excipients |
|---|
|
Castor oil for injection |
Carton containing one 1ml glass ampoule.
Bayer plc, 400 South Oak Way, Reading, RG2 6AD
PL 00010/0548
23 February 2009
| Drug | Countries | |
|---|---|---|
| NORISTERAT | Mexico, Nigeria, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
